Pharma Mirror Magazine

  • Home
  • Articles
  • Global News
  • Interest
  • Global Events
    • Add Event
  • Health Tips
  • Knowledge
    • Drug Directory
    • Education
      • Pharmacy Case Study
      • Pharmacy eBook Reviews
    • Pharma Companies
    • Dictionary Online
    • Career
    • Pharma Video
    • Featured Pharma Leader
  • About
    • Contact Us
    • Write for Us
    • Privacy Policy

Mobile Logo

Browse Tag

Maculus Therapeutix

Maculus Therapeutix welcomes Privity FZ LLE and Prepares Capital Raise for Novel Drug Delivery Platform
Pharmaceutical News

Maculus Therapeutix welcomes Privity FZ LLE and Prepares Capital Raise for Novel Drug Delivery Platform

February 18, 2021February 18, 2021

Maculus Therapeutix, a preclinical-stage biopharmaceutical company which has developed a SINGLE injection delivery platform for diseases such as wet AMD

More

Subscribe

Subscribe our Articles, please enter your email below:

Please verify the email sent to your inbox to complete the subscription process. It's safe and free too.

Recent Posts

  • Novartis Piqray(R) – First and only treatment specially for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer receives HSA approval March 1, 2021
  • Accelerating Investigator Recruitment with NLP March 1, 2021
  • New Sales Directors at Romaco in Cologne, Bologna and Karlsruhe February 26, 2021
  • Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site February 24, 2021
  • The Wholesome Value of Holistic Wellness Treatments February 19, 2021

Event Partnership

Purify India

© 2010-2020 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Global Events
    • Add Event
  • Health Tips
  • Knowledge
    • Drug Directory
    • Education
      • Pharmacy Case Study
      • Pharmacy eBook Reviews
    • Pharma Companies
    • Dictionary Online
    • Career
    • Pharma Video
    • Featured Pharma Leader
  • About
    • Contact Us
    • Write for Us
    • Privacy Policy
Go toTop